Related references
Note: Only part of the references are listed.Cell membrane-formed nanovesicles for disease-targeted delivery
Jin Gao et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection
Dafeng Chu et al.
ACS NANO (2015)
New trends in guided nanotherapies for digestive cancers: A systematic review
Elisabete Fernandes et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Stimuli-sensitive nanopreparations for combination cancer therapy
Aditi Jhaveri et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils
Zhenjia Wang et al.
NATURE NANOTECHNOLOGY (2014)
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Vladimir P. Torchilin
NATURE REVIEWS DRUG DISCOVERY (2014)
The Multifaceted Functions of Neutrophils
Tanya N. Mayadas et al.
Annual Review of Pathology-Mechanisms of Disease (2013)
Neutrophils mediate antibody-induced antitumor effects in mice
Marcello Albanesi et al.
BLOOD (2013)
Targeting tumors with nanobodies for cancer imaging and therapy
Sabrina Oliveira et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Photodynamic nanomedicine in the treatment of solid tumors: Perspectives and challenges
Alyssa Master et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Targeted nanotheranostics for personalized cancer therapy
Odile Diou et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Advancement in multifunctional nanoparticles for the effective treatment of cancer
Mahfoozur Rahman et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Combination strategies to enhance antitumor ADCC
Holbrook E. Kohrt et al.
IMMUNOTHERAPY (2012)
Albumin-based nanoparticles as potential controlled release drug delivery systems
Ahmed O. Elzoghby et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Analysis on the current status of targeted drug delivery to tumors
Il Keun Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Vikash P. Chauhan et al.
NATURE NANOTECHNOLOGY (2012)
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Sarbari Acharya et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Delivery of Nanoparticle-complexed Drugs across the Vascular Endothelial Barrier via Caveolae
Zhenjia Wang et al.
IUBMB LIFE (2011)
Cancer nanotechnology: application of nanotechnology in cancer therapy
Ranjita Misra et al.
DRUG DISCOVERY TODAY (2010)
Effects of potential calcium sensing receptor inducers on promoting chemosensitivity of human colon carcinoma cells
Xize Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Size and Dynamics of Caveolae Studied Using Nanoparticles in Living Endothelial Cells
Zhenjia Wang et al.
ACS NANO (2009)
Impact of Nanotechnology on Drug Delivery
Omid C. Farokhzad et al.
ACS NANO (2009)
Neutrophils in antibody-based immunotherapy of cancer
Marjolein van Egmond
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
K Langer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins
K Toyofuku et al.
FASEB JOURNAL (2001)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Share Paper
